Nanoparticle comprising rapamycin and albumin as anticancer agent
US-2025186359-A1 · Jun 12, 2025 · US
Abraxis Bioscience Llc holds 135 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 135 |
| Recent patents | 14 |
| First publication | Jan 6, 2015 |
| Latest publication | Jun 12, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2025186359-A1 · Jun 12, 2025 · US
US-12324860-B2 · Jun 10, 2025 · US
US-2025152563-A1 · May 15, 2025 · US
US-12133844-B2 · Nov 5, 2024 · US
US-2024299313-A1 · Sep 12, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2025186359-A1 · Jun 12, 2025 · US
US-12324860-B2 · Jun 10, 2025 · US
US-2025152563-A1 · May 15, 2025 · US
US-12133844-B2 · Nov 5, 2024 · US
US-2024299313-A1 · Sep 12, 2024 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 134 |
| Chemistry & Metallurgy | 29 |
| Physics | 24 |
| Cross-Sectional Technologies | 16 |
| Operations & Transport | 14 |
Answers are generated from the same data shown on this page.